Laboratory of Infectious Diseases, National Institute for Allergy and Infectious Diseases, NIH, Bethesda, Maryland 20892-3203, USA.
J Virol. 2010 Feb;84(3):1289-301. doi: 10.1128/JVI.01281-09. Epub 2009 Nov 11.
We characterized the cellular immune response to severe acute respiratory syndrome coronavirus (SARS-CoV) infection in 12- to 14-month-old BALB/c mice, a model that mimics features of the human disease. Following intranasal administration, the virus replicated in the lungs, with peak titers on day 2 postinfection. Enhanced production of cytokines (tumor necrosis factor alpha [TNF-alpha] and interleukin-6 [IL-6]) and chemokines (CXCL10, CCL2, CCL3, and CCL5) correlated with migration of NK cells, macrophages, and plasmacytoid dendritic cells (pDC) into the lungs. By day 7, histopathologic evidence of pneumonitis was seen in the lungs when viral clearance occurred. At this time, a second wave of enhanced production of cytokines (TNF-alpha, IL-6, gamma interferon [IFN-gamma], IL-2, and IL-5), chemokines (CXCL9, CXCL10, CCL2, CCL3, and CCL5), and receptors (CXCR3, CCR2, and CCR5), was detected in the lungs, associated with an influx of T lymphocytes. Depletion of CD8(+) T cells at the time of infection did not affect viral replication or clearance. However, depletion of CD4(+) T cells resulted in an enhanced immune-mediated interstitial pneumonitis and delayed clearance of SARS-CoV from the lungs, which was associated with reduced neutralizing antibody and cytokine production and reduced pulmonary recruitment of lymphocytes. Innate defense mechanisms are able to control SARS-CoV infection in the absence of CD4(+) and CD8(+) T cells and antibodies. Our findings provide new insights into the pathogenesis of SARS, demonstrating the important role of CD4(+) but not CD8(+) T cells in primary SARS-CoV infection in this model.
我们对 12-14 个月大的 BALB/c 小鼠进行了严重急性呼吸综合征冠状病毒(SARS-CoV)感染的细胞免疫反应特征分析,这是一种模拟人类疾病特征的模型。病毒经鼻腔给药后,在肺部复制,感染后第 2 天达到峰值滴度。细胞因子(肿瘤坏死因子-α[TNF-α]和白细胞介素-6[IL-6])和趋化因子(CXCL10、CCL2、CCL3 和 CCL5)的大量产生与 NK 细胞、巨噬细胞和浆细胞样树突状细胞(pDC)向肺部迁移相关。到第 7 天,当病毒清除时,肺部出现肺炎的组织病理学证据。此时,在肺部检测到第二波增强的细胞因子(TNF-α、IL-6、γ干扰素[IFN-γ]、IL-2 和 IL-5)、趋化因子(CXCL9、CXCL10、CCL2、CCL3 和 CCL5)和受体(CXCR3、CCR2 和 CCR5)的产生,这与 T 淋巴细胞的涌入有关。在感染时耗尽 CD8+T 细胞不会影响病毒复制或清除。然而,耗尽 CD4+T 细胞会导致免疫介导的间质性肺炎增强,并延迟 SARS-CoV 从肺部清除,这与中和抗体和细胞因子产生减少以及淋巴细胞在肺部募集减少有关。在没有 CD4+和 CD8+T 细胞和抗体的情况下,先天防御机制能够控制 SARS-CoV 感染。我们的研究结果为 SARS 的发病机制提供了新的见解,表明在该模型中,CD4+T 细胞而非 CD8+T 细胞在 SARS-CoV 原发性感染中起重要作用。